165 related articles for article (PubMed ID: 7791265)
41. Etiology and clinical implications of eosinophilic pleural effusions.
Riantawan P; Bangpattanasiri K; Chaowalit P; Sangsayan P
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):655-9. PubMed ID: 10437974
[TBL] [Abstract][Full Text] [Related]
42. Antibody detection for the diagnosis of tuberculous pleuritis.
Chierakul N; Damrongchokpipat P; Chaiprasert A; Arjratanakul W
Int J Tuberc Lung Dis; 2001 Oct; 5(10):968-72. PubMed ID: 11605893
[TBL] [Abstract][Full Text] [Related]
43. Differential levels of cytokines and soluble Fas ligand between tuberculous and malignant effusions.
Cui HY; Zhang Q; Su B; Li W; Tang SJ
J Int Med Res; 2010; 38(6):2063-9. PubMed ID: 21227011
[TBL] [Abstract][Full Text] [Related]
44. [Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].
Tian RX; Gao ZC
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):435-8. PubMed ID: 15312552
[TBL] [Abstract][Full Text] [Related]
45. [Type III procollagen N-terminal aminopeptide and type IV collagen 7S in pleural effusion fluid].
Tsuchiya Y; Nishikawa M; Iwamoto K; Kirioka T; Noguchi M; Watanabe A; Nishiwaki K; Nozaki Y; Nakane Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):622-6. PubMed ID: 9294295
[TBL] [Abstract][Full Text] [Related]
46. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
Porcel JM; Gázquez I; Vives M; Pérez B; Rubio M; Rivas MC
Int J Tuberc Lung Dis; 2000 Oct; 4(10):975-9. PubMed ID: 11055766
[TBL] [Abstract][Full Text] [Related]
48. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
49. Complement activation products in plasma after heart transplantation in humans.
Vallhonrat H; Williams WW; Dec GW; Keck S; Schoenfeld D; Cosimi AB; Pascual M
Transplantation; 2001 May; 71(9):1308-11. PubMed ID: 11397968
[TBL] [Abstract][Full Text] [Related]
50. [A study on the model of tuberculous pleurisy and intrapleural inflammatory and immunological responses in rats].
He Q; Xie CM; Tan SY; Zhang KX; Deng XH; Zhu PB; Yi XP; Zhang YL; Cai XS; Huang LJ; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):117-21. PubMed ID: 15854395
[TBL] [Abstract][Full Text] [Related]
51. Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome.
Ferraris JR; Ferraris V; Acquier AB; Sorroche PB; Saez MS; Ginaca A; Mendez CF
Clin Exp Immunol; 2015 Jul; 181(1):118-25. PubMed ID: 25677399
[TBL] [Abstract][Full Text] [Related]
52. Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization.
Aguiar LM; Antonangelo L; Vargas FS; Zerbini MC; Sales MM; Uip DE; Saldiva PH
Clinics (Sao Paulo); 2008 Oct; 63(5):637-44. PubMed ID: 18925324
[TBL] [Abstract][Full Text] [Related]
53. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
54. The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome.
Parsons PE; Giclas PC
Am Rev Respir Dis; 1990 Jan; 141(1):98-103. PubMed ID: 2297192
[TBL] [Abstract][Full Text] [Related]
55. [Changes in complement breakdown products and terminal complement complex in patients with acute glomerulonephritis].
Kojima H; Ohi H; Seki M; Hatano M
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):925-31. PubMed ID: 2585834
[TBL] [Abstract][Full Text] [Related]
56. Activation of the complement system by different autologous transfusion devices: an in vitro study.
Tylman M; Bengtson JP; Bengtsson A
Transfusion; 2003 Mar; 43(3):395-9. PubMed ID: 12675727
[TBL] [Abstract][Full Text] [Related]
57. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
[TBL] [Abstract][Full Text] [Related]
58. [The changes and clinical significance of interleukin 1 beta in pleural effusion].
Yang T; Han L; Wang B
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):85-7, 127-8. PubMed ID: 7553957
[TBL] [Abstract][Full Text] [Related]
59. Th1/Th2 Imbalance and Elevated PD-L1 in Pleural Effusion Predict the Risk of Multi-Drug Resistant Tuberculous Pleuritis.
Xu H; Yang Y; Wu Q; Zhang Y
Iran J Immunol; 2020 Mar; 17(1):1-13. PubMed ID: 32224537
[TBL] [Abstract][Full Text] [Related]
60. [Evaluation of plasma SC5b-9 (SMAC) in patients with ARDS].
Hara N; Abe M; Kawarada Y; Inuzuka S; Takahashi H; Goya T; Shigematsu N; Fujita T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):796-801. PubMed ID: 1630043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
